Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b

BMC Gastroenterology

Britta Siegmund³  Hans-Jörg Epple³  Ursula Plöckinger²  Moritz von Winterfeld¹  Christoph Treese³  Mani Nassir³  Magdalena Sarah Volz³ 

[1] Institute of Pathology, Charité – Universitätsmedizin Berlin, Berlin, Germany;Interdisciplinary Center of Metabolism: Endocrinology, Diabetes and Metabolism, Charité – Universitätsmedizin Berlin, Berlin, Germany;Department of Medicine I (Gastroenterology, Rheumatology, Infectious Diseases), Charité – Universitätsmedizin Berlin, Berlin, Germany

关键词: G-CSF;    Granulocyte colony stimulating factor;    Glycogen storage disease;    Glycogenosis;    Stenosis;    IBD-like disease;    Crohn’s disease;   

Others  :  1211543
DOI  :  10.1186/s12876-015-0271-9

 received in 2015-01-25, accepted in 2015-03-20,  发布年份 2015

【 摘 要 】

Background

Inflammatory bowel disease (IBD)-like conditions in glycogen storage disease (GSD) type Ib have been predominantly described in children. Signs and symptoms of GSD type Ib are hypoglycemia, pancytopenia and hepatosplenomegaly. Based on few published cases, there is evidence that granulocyte-colony stimulating factor (G-CSF) in patients with glycogenosis–related pancytopenia might ameliorate the IBD-like disease through leukocyte increase.

Case presentation

Here we firstly describe a case of an adult 33-year-old Caucasian male patient with GSD type Ib accompanied with IBD-like disease with persistent pancytopenia despite moderate-dose G-CSF treatment. Recent vomiting and abdominal discomfort were due to a high-grade stenosis in the transverse colon. A dose increase of the G-CSF successfully normalized his leukocyte count. However, the stenosis worsened and surgical therapy was needed.

Conclusion

We suggest that symptomatic patients with GSD type Ib should undergo endoscopic examination in order to detect IBD-like disease and to initiate early treatment.

【 授权许可】

   
2015 Volz et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 4.

【 参考文献 】

• [1]Kure S, Suzuki Y, Matsubara Y, Sakamoto O, Shintaku H, Isshiki G, et al.: Molecular analysis of glycogen storage disease type Ib: identification of a prevalent mutation among Japanese patients and assignment of a putative glucose-6-phosphate translocase gene to chromosome 11. Biochem Biophys Res Commun 1998, 248(2):426-31.
• [2]Schaub J, Heyne K: Glycogen storage disease type Ib. Eur J Pediatr 1983, 140(4):283-8.
• [3]Alsultan A, Sokol RJ, Lovell MA, Thurman G, Ambruso DR: Long term G-CSF-induced remission of ulcerative colitis-like inflammatory bowel disease in a patient with glycogen storage disease Ib and evaluation of associated neutrophil function. Pediatr Blood Cancer 2010, 55(7):1410-3.
• [4]Melis D, Parenti G, Della Casa R, Sibilio M, Berni Canani R, Terrin G, et al.: Crohn’s-like ileo-colitis in patients affected by glycogen storage disease Ib: two years’ follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatr 2003, 92(12):1415-21.
• [5]Roe TF, Thomas DW, Gilsanz V, Isaacs H Jr, Atkinson JB: Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr 1986, 109(1):55-9.
• [6]Kratzer W, Foeller T, Kaechele V, Reinshagen M, Tirpitz CV, Haenle MM: [Intestinal wall vascularisation in Crohn’s disease]. Z Gastroenterol 2004, 42(9):973-8.
• [7]Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ: Sargramostim for active Crohn’s disease. N Engl J Med 2005, 352(21):2193-201.
• [8]Saltik-Temizel IN, Kocak N, Ozen H, Yuce A, Gurakan F, Demir H: Inflammatory bowel disease-like colitis in a young Turkish child with glycogen storage disease type 1b and elevated platelet count. Turk J Pediatr 2005, 47(2):180-2.
• [9]Wendel U, Bremer HJ, Willberg B: Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr 1987, 110(1):166.
• [10]Yamaguchi T, Ihara K, Matsumoto T, Tsutsumi Y, Nomura A, Ohga S, et al.: Inflammatory bowel disease-like colitis in glycogen storage disease type 1b. Inflamm Bowel Dis 2001, 7(2):128-32.
• [11]Sanderson IR, Bisset WM, Milla PJ, Leonard JV: Chronic inflammatory bowel disease in glycogen storage disease type 1B. J Inherit Metab Dis 1991, 14(5):771-6.
• [12]de Parscau L, Maire I, Guibaud P, Gonthier R, Dumollard JM, Rousset H: Glycogen storage disease and inflammatory bowel disease. J Pediatr 1989, 115(2):337.
• [13]Schulman H, Weizman Z, Barki Y, Maor E, Hertzanu Y: Inflammatory bowel disease in glycogen storage disease type 1 B. Pediatr Radiol 1995, 25(Suppl 1):S160-2.
• [14]Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, et al.: Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr 2000, 137(2):187-91.
• [15]Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V: Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med 1992, 326(25):1666-9.
• [16]Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K, et al.: Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1. Eur J Pediatr 2002, 161 Suppl 1:S83-7.
• [17]Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D: The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 2013, 67:46-51.